✦ LIBER ✦

[RSC Drug Discovery] Neurodegeneration Volume 0 || Chapter 3. Proteostasis as a Signaling Device and Therapeutic Target

✍ Scribed by Milardi, Danilo; Rizzarelli, Enrico

Book ID: 119997325
Publisher: Royal Society of Chemistry
Year: 2011
Tongue: English
Weight: 262 KB
Edition: 1
Category: Article
ISBN: 1849730504
DOI: 10.1039/9781849733014-00046

No coin nor oath required. For personal study only.

✦ Synopsis

This Book Covers The Latest Developments In The Understanding The Pathogenesis Of Neurodegenerative Diseases. Danilo Milardi And Enrico Rizzarelli (editors). Includes Bibliographical References And Index. Mode Of Access: World Wide Web.

📜 SIMILAR VOLUMES

[RSC Drug Discovery] Neurodegeneration V

[RSC Drug Discovery] Neurodegeneration Volume 0 || Chapter 2. Chemistry and Biology of Proteostasis

✍ Milardi, Danilo; Rizzarelli, Enrico 📂 Article 📅 2011 🏛 Royal Society of Chemistry 🌐 English ⚖ 693 KB

[RSC Drug Discovery] Metabolism, Pharmac

[RSC Drug Discovery] Metabolism, Pharmacokinetics and Toxicity of Functional Groups Volume 0 || Chapter 8. Peptidomimetics and Peptides as Drugs: Motifs Incorporated to Enhance Drug Characteristics

✍ Smith, Dennis A 📂 Article 📅 2010 🏛 Royal Society of Chemistry ⚖ 638 KB

Knowledge-Based Identification of the ER

Knowledge-Based Identification of the ERK2/STAT3 Signal Pathway as a Therapeutic Target for Type 2 Diabetes and Drug Discovery

✍ Takayoshi Kinoshita; Kentaro Doi; Hajime Sugiyama; Shuhei Kinoshita; Mutsuyo Wad 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB

[RSC Drug Discovery] Physico-Chemical an

[RSC Drug Discovery] Physico-Chemical and Computational Approaches to Drug Discovery Volume 684 || Chapter 10. COMparative BINding Energy (COMBINE) Analysis as a Structure-Based 3D-QSAR Method†† Dedicated to our late colleague and friend Angel R. Ortiz.

✍ Luque, Javier; Barril, Xavier 📂 Article 📅 2012 🏛 Royal Society of Chemistry ⚖ 649 KB

[RSC Drug Discovery] New Therapeutic Str

[RSC Drug Discovery] New Therapeutic Strategies for Type 2 Diabetes Volume 74 || Chapter 11. The Discovery and Development of MB07803, a Second-Generation Fructose-1,6-bisphosphatase Inhibitor with Improved Pharmacokinetic Properties, as a Potential Treatment of Type 2 Diabetes

✍ Jones, Rob M 📂 Article 📅 2012 🏛 Royal Society of Chemistry ⚖ 720 KB